Full Transcript Introduction to Peptides and the Summit 0:00 Welcome to the Bioregulator and Peptide Summit, folks. 0:04 My guest today is well, she's quite apart from being awesome. 0:07 She's a dear friend of mine and I feel very grateful to have her as a friend. 0:11 So thank you, Doctor Melissa Petersen, for being here. 0:14 Oh, thank you for having me. 0:16 Likewise, My darling. 0:17 You're one of my favorites. Yeah. 0:19 So today we're talking about the future of medicine, which 0:24 that was what somebody the first time I ever heard about peptides. 0:27 That's what somebody said to me. And I'm like, are you kidding me? 0:29 And he's like, nope. 0:30 And listen, we are all excited about peptides. 0:33 They're everywhere right now and for good reason, right? 0:36 Yeah. But here's the thing. 0:37 Are they actually the future or might they be the gateway into something 0:41 much bigger? 0:42 So Doctor Melissa grilled Petersen. 0:44 For the few of you who might have been living under a rock 0:46 and don't know who she is, is a true global leader in jeopardy. 0:50 How spent and the future of human health. 0:52 She's the founder of Human Longevity Global and the visionary 0:55 behind my Peptide University. 0:58 If you don't know what my peptide university is, I don't care 1:01 if you're practitioner or a person, just a regular person. 1:04 Go find it at my peptide university. 1:08 See, I'm even giving you the URL and the Human Longevity Institute. 1:12 She is a TEDx speaker, bestselling author, educator, and thought leader known 1:16 for translating cutting edge science into real world strategies for clinicians 1:20 and consumers alike. 1:22 So once again, Doctor Melissa, welcome. 1:25 Thank you, my darling. 1:26 I so appreciate this and I'm really looking forward 1:31 to the conversation we're going to share with your audience today. 1:33 Yes, I love it. 1:34 So let's start with the big question. 1:38 What happened? 1:39 Why has the world suddenly become so obsessed. 1:42 And that's not a word I use lately. 1:43 Like some people with peptides. 1:45 What's I mean, it's like a fascination fixation. 1:49 Obsession. What happened? 1:50 You know, we could try to put it into the category 1:54 of just pop culture and just say it's the trend, it's the fad. 1:57 But as a clinician, as someone who has worked 2:00 with these small molecules myself for greater than a decade, 2:04 watching them in clinical practice, growing in popularity, I mean, you know, 2:08 the first one was over 100 years ago as insulin. 2:10 But even over the past 20 years, the utilization of these, 2:14 I step back and I see it a little differently. 2:16 I really think that our obsession is because there's something 2:20 finally that represents possibility. 2:23 And that's, you know, that's that's really the biggest thing 2:25 because they kind of came on the scene with the Jim Bros. 2:29 And vanity. 2:30 But what people what I love about that is it started 2:34 the conversation and people got curious. Right. 2:36 And it was solving a pain point. 2:38 But then as they dove into that and they listen to, you know, 2:42 podcasts and sessions like this, information 2:45 like this, they realized, wait, these do far more 2:50 than just help me to look super cute in my outfit. 2:53 It's all about longevity 2:54 and performance and recovery and healing and personalization and like, 2:58 real world healing solutions versus just treating and managing symptoms. 3:04 Because let's face it, I think so many of us 3:06 have been let down, disappointed, frustrated by sick care model 3:10 the management of the problem right pill for ill. 3:12 We've all kind of heard those statements. 3:14 So I love these beautiful little molecules because I think that really 3:19 they kind of give us a glimpse into a more intelligent 3:23 and really customized future of personalized healthcare. 3:28 Yeah, I love that. 3:29 So I'm going to ask a question. 3:30 I'm going to add a little bit to it here okay. 3:33 Our peptides actually revolutionary or is some of this hype. 3:36 And I will add to this that in the ugly nasty world 3:41 that is social media these days.
Why Peptides Became So Popular 3:43 There's no shortage of medical doctors and researchers claiming, 3:48 yeah, that this is all hype and it's all there's 3:51 no research, there's no human trials, there's no. 3:55 But you know what I mean? 3:56 Like, I mean, up until when I got kicked off of Instagram 3:59 a couple of weeks ago, I'd rather unceremoniously my feet was starting 4:03 to get filled with these people. 4:06 And I'm like, wow. 4:08 Like, is it? Are they being bitter? Betty's. 4:10 Are they right? 4:11 Like what? 4:12 What do we make of this? 4:13 You know, it's so, so interesting. 4:16 And recently, like, I'll tell you, one of the things that I truly don't 4:20 look at any comments on my social media, I don't want to I don't want 4:25 to get into it really, really, because we all have an opinion, right? 4:28 And a lot of it there's especially on this topic, 4:31 there's a lot of bots out there, and we know what feeds 4:34 the algorithm is a contentious, you know, controversial stance and size. 4:39 And I think what's happening is because of the popularity, 4:43 because of the conversation that's happening everywhere. 4:47 I think that trained licensed physicians especially, and I'm not physician bashing, 4:52 I'm getting really clear, but I believe they're trying to draw a line in the sand 4:57 to find their own stance, to separate amongst the influencers. 5:01 And so instead of being able to feel like they can lean in and understand 5:05 where they fit, because they we were not trained about this 5:09 in any conventional medical training, which is why we do. 5:12 We're so that's why my peptide University was born, right? 5:16 To be able to bring out a standardized, you know, curriculum of care. 5:21 Like we're really setting standards of care 5:23 so that whether you're a prescriber or non prescriber, because these molecules 5:27 are not just gated only by a prescription pad. 5:30 And I think because of that, it's it 5:33 and because of the popularity it is creating. 5:37 Well this should just be left to this person 5:39 or that like I'm seeing getting ugly comments. 5:42 Yeah. 5:42 And yet so there is a ton of hype and so on. 5:46 One part 5:47 they're they're not necessarily it's not just a black or white right or wrong. 5:51 It's an and also shades of gray. 5:53 Even how we access peptides, there are shades of gray. 5:56 And I'm not just talking the gray market. 5:57 What I mean by this is there is plenty of hype. 6:01 But again there, you know, and I think because the reason 6:06 that certain practitioners might be calling them hype 6:09 or saying they're unfounded 6:10 or saying there's not enough evidence, again, a lot of the clinical trials, 6:14 a lot of the studies, a lot of the data points 6:17 have been in animal models, with the exception of GLP. 6:20 And we know that some igloo type is the most research and it is a peptide. 6:26 So if we just went on that one molecule alone, 6:30 well that negates there is no argument. 6:32 It's the most research. 6:33 It's got human trials. 6:35 It's one of the most popular. 6:36 It's one of the most most consumed. 6:39 It's driven the market of pharmaceuticals that we're about to be at 100 billion 6:43 in, just like two more years. 6:45 Rejection. 6:45 So unfortunately, everybody wants to have a voice. 6:48 Everybody wants to have a position. 6:50 And we know when it comes to social media. 6:52 I balls are controversy. 6:54 And if I'm going to bash 6:56 something, people might not like it, but they'll be like, yeah, yeah, yeah. 7:00 And it'll get me views and it'll get me shares. 7:02 And now all of a sudden I matter. 7:05 I've got eyes. 7:06 But we are dismissing the real magic here. 7:12 And the magic isn't the peptide. 7:15 That's another thing that people want to say. 7:17 Well, that's why it's hype. No, it is science. 7:19 It is evidence based. 7:21 And again, let's remember that many like, where did you and I know 7:27 this small chains of amino acids bonded together. 7:31 Amino acids, amino acids come together. 7:35 We form amino acids, peptides, polypeptides, proteins right there. 7:39 It's it's just a little bit of the protein. 7:42 They don't make them. 7:43 There's nothing there's nothing non evidence based. 7:46 Our very DNA is made of these same elements. 7:50 Like all this is is very specific code that comes together right. 7:54 To build to repair to signal to communicate in the body. 7:57 And so what I believe we get to appreciate is their evidence base. 8:03 They work so much so that we are making them in a synthetic 8:08 or exogenous form to take in, to support healing, repair, right? 8:13 As well as metabolic health, cognitive health, longevity, health, 8:17 reproductive health. 8:18 We are utilizing these molecules in many ways, and they're not brand new, 8:23 but I see them as a true gateway. 8:27 And that's kind of what we said. 8:28 Even as you introduced me, you know, they are a gateway into 8:32 they're not going away. 8:33 They are opening up an entirely new conversation. 8:36 And I'll tell you the 8:36 I think one of the other big things is the reality of 8:39 if a doctor hasn't been trained on something 8:41 and now they're going to ask questions about something 8:42 and they don't 8:43 know how to intelligently answer it, the easiest thing to say is, 8:46 well, that's not evidence based. That's not real. 8:47 That's that's hype. 8:49 Yeah. 8:49 Because they don't want to they don't want to look less than. 8:52 And to me, I think those are the exact moments we lean in with curiosity. 8:56 And because it's not just the prescriber, we've all been lacking in that education. 9:02 So what a great time the consumer demand is there. 9:05 Why not leaned in? 9:06 Because healthcare is evolving. 9:08 These molecules are the gateway to a much larger conversation 9:12 and an entirely new model that's here. 9:13 Whether we like it or not, 9:15 we can say it's crap all day long, but it's not going away. 9:18 Yeah, no, I agree. 9:19 And I think that, you know, so many of these small molecules, 9:23 peptides, there are actual receptors for them in the body. 9:27 That in and of itself tells us that there's a place for them, 9:30 there's an intelligent way to do it and a not intelligent way to do it. 9:34 There's lots of pitfalls, some of which we're going to talk about, 9:37 but it's filled with that word that people just seem to have forgotten about. 9:42 It's filled with nuance. Yeah. 9:44 And it's there's you have to be able to again, 9:47 you have to be able to hold two truths at the same time. 9:49 Like all of those things people hate that the algorithm doesn't feed, 9:53 you know, all of those things just, you know, and 9:57 and obviously we stop it saying everybody should be doing this. 10:01 And this is where, you know, this is where the influencer model really falls apart 10:06 and is has given those people a reason to have that voice in a way. 10:12 Yeah. So all right. 10:13 So what's the biggest misconception people have about peptides in your opinion? 10:18 Yeah. 10:18 The biggest one is the tide. Yeah. 10:20 That the peptide is the answer. 10:21 Like legitimately like they think they just need the thing. 10:24 And and this is not anyone's fault because I believe that this is 10:28 how we're all conditioned as consumers. 10:31 If you just think of what capitalism is, it's all about I mean, like 10:35 how how did it all start, you know, forever go back in the 1800s. 10:39 The snake oil is a thing. 10:41 I mean, literally Listerine was was a freaking 10:44 like stripped varnish off the floor and they found a different way to use it. 10:47 Hey, you don't want to think and smell and be bad
Hype vs Evidence in Peptide Medicine 10:50 and be ostracized by everybody, do you? 10:52 And they started to sell this thing like it's it like, look it up. 10:54 It's real as factual article, you know. 10:57 But this idea that started back in the 1800s to sell. 11:02 And how did selling happen? 11:04 Selling to a deficiency, to a lack, to a fear. 11:08 And so we have all been conditioned. 11:10 It's not just about a peptide. It's about anything. 11:13 Whether it's the shoe, the purse, the the car, the house, the degree. 11:17 Like I need the thing because that says something 11:22 about me and it's usually an outcome that we want. 11:25 And so the misconception is, my gosh, peptides are everywhere. 11:29 And so we're popping them like candy. 11:31 And so we think that they're just like these benign, really fun, 11:34 trendy things like taking a fat burner back in the 90s. 11:37 That's not what these are. 11:41 These are very potent intelligent 11:44 cell signaling molecules that do real things in the body. 11:48 Like. 11:48 And it blows my mind how people are just so willing 11:54 to put something into their body because they think it's a trend 11:57 and they can be cool and they can get likes and views, 12:00 and they have no understanding, really, 12:04 of how this is interacting with other medications they may be taking, 12:08 right, with what their terrain is like, what is their current state of health. 12:11 And so and we'll probably unpack this as we have time today. 12:14 But when we look at the regulatory landscape and the massive shift 12:18 that has happened just in the past couple of months, 12:20 I think going on for a year, silently, we knew it was coming. 12:23 But when we see this major shift in the ability to access peptides 12:27 through research use only or the direct to consumer lane, it's now more gated. 12:32 It's regulated 12:33 because it's been over $100 billion industry that had zero oversight. 12:37 Nobody was looking at it. 12:39 So it means like, what's in the bottle? 12:41 Who the heck knows? 12:42 It doesn't matter if there's a label on it. 12:44 It could say it's read a true tide all day long. 12:46 It could be talcum powder. Right? 12:47 So there's nobody that's inspecting it, verifying it. 12:50 And when you can charge the kind of money 12:52 that you can charge to get a bottle of talcum powder or baking soda versus 12:56 the real thing, like people like, we want to all think people are good. 12:59 But if I've learned one thing in this industry every day, I'm just like, 13:03 it's which side of the drug dealing? 13:06 And I don't mean this negatively because I love peptides, 13:08 but I'm like, it's a dirty industry and there's a lot of people 13:11 trying to make a buck 13:12 that don't have the best interest of that end user in mind at all. 13:17 They'll tell you it's the best thing since sliced bread. 13:19 They don't care what happens. You buy it, you can't. 13:22 There's no recourse. You can't. 13:24 You can't go get their mouth, their license. 13:26 You can't go to them. You can't do. 13:28 Which I don't want you to do in anybody. Right? 13:29 But I mean, like, there's zero recourse. 13:32 And so the gating and the understanding, the misconception 13:36 that it's just the peptide and then they go, well, 13:37 it didn't work or why didn't work or, or this I'm just a little must be good. 13:41 A lot must be better. 13:43 We hear a story after story after story of of health crises 13:47 and people going into the emergency room for a multitude of reasons. 13:52 And I'm going to tell you, 13:52 a lot of these people are health practitioners themselves. 13:55 And so what's happening is these being real, powerful medicines. 14:02 And when I say a medicine is it's it's got a, 14:05 you know, because it's not just to treat 14:07 like I want to some of us in the integrative space 14:09 or natural space, we don't like that word medicine. 14:11 But I want you to think of it that it's it's sending a signal, it's 14:13 sending a message in your body and a really powerful signal at that. 14:17 Like we're talking micrograms in cases. 14:20 Exactly. 14:20 And you and I have talked a lot about this. 14:22 And that's one of the things. 14:23 Thank you for saying that because, you know, one of the things that's 14:26 really fascinating to me that I love inside of. 14:29 So one of the things inside of my peptide university, 14:32 a big part of what we are is we're community, right? 14:34 So every week there's office hours, there's new trainees, there's new. 14:38 And I would say the term I use for people to think that we crowdsource. 14:41 So we have clinicians of every different 14:43 type and background and amount of years in practice. 14:46 Some are brand new, some have been using peptides 14:48 for again, well over a decade, two decades in different genres and specialty. 14:52 And so literally two weeks ago, we were having a call with our pharmacist 14:56 and we were talking about the molecule. 14:57 Here's an example. We were talking about SS 31. 15:00 And so when you look at some of these mitochondrial peptides as an example, 15:04 and this is getting back to the misconception is 15:07 there's quite a range of dosing. 15:09 So it can be from five milligrams. 15:10 And c is quite similar from five upwards of 20 okay. 15:15 And so but yet what we are finding 15:19 especially with these mitochondrial enhancers, 15:21 it's like clinically we have to look at how does this client or patient present 15:25 what have been the inputs to the system. 15:27 What's been the stressors 15:29 physical, mental, emotional, chemical, environmental. 15:31 The big t little t traumas, 15:33 what has brought them in, what has gotten their system to this point? 15:37 And it's not just about putting a really powerful 15:41 and potent signal in to this dysfunctional terrain. 15:45 It's not going to work for a lot of reasons. 15:47 Okay, we can try to drive the system, but what outcome do we really want? 15:51 That's what working with a clinician, a trained clinician in this, 15:55 in this field of expertise helps with they help to see the blind spots. 16:00 They help to have a framework just about the peptide. 16:03 It's not like a supplement. 16:05 It's not just a piece of candy that we pop in. 16:08 And so half of us on that call talked about because of the type of patients 16:13 we had, we were seeing more like Doctor Remco was talking about with SS 31. 16:19 She was literally having a lot of cases where she was doing one milligram 16:22 and like the results that she was seeing were tremendous. 16:26 Now she's also doing 16:27 terrain prep, so she's a little bit more on that integrative side. 16:30 Right. 16:30 And she's able to do some other things she is really working with kind of 16:34 like mitochondrial principles, foundational health principles. 16:37 First, Doctor Cleaver is doing a lot of cancer work, 16:41 and he was at higher doses now in that in the more of the kind 16:45 of allopathic side, there wasn't as much terrain prep. 16:49 And so now the higher doses were effective. 16:52 But they had to approach it 16:53 totally differently based on the other medications 16:55 that were there, why they were needing that. 16:57 And just for a moment, gang, the reason that SS 31 is such an important 17:02 molecule is because it literally repairs the cell membrane. 17:07 And when we use peptides and this comes back and I'll close out 17:11 my point as the misconception, it's not just the molecule. 17:15 The peptide is only as good as that cell surface the receptor. 17:20 So Natalie, you just you know, you said it yourself 17:22 like, look we have receptors lock and key gang. 17:24 It fits in these certain places. 17:25 And so if that cell membrane where these receptors are is worn down, 17:30 it's like they literally break down based on the inflammatory lows. 17:33 Again, we can get into that if we want to. 17:35 But as they break down because of we'll just call it the stress, the low, 17:39 the impact of life, the dysregulation in the system, 17:43 the peptide can be in there, which you can be paying a lot of money 17:46 to put in there, but it doesn't seem to be working. 17:48 And then we think we have to go higher dose and higher dose and higher dose, 17:51 and then we don't know how to deescalate and then we get afraid to come off of it. 17:53 And then why isn't it working? I spend a lot of money. And is it this. 17:56 It's like breathe realize they get outcomes. 18:02 It works as well as the train we put it into. 18:05 Which is why clinicians need clinical frameworks, and they need to have 18:09 the conversation to be able to help their clients, their patients feel safe, 18:14 feel seen, feel heard, feel comfortable taking the journey. 18:18 And you know this yourself. 18:19 We've talked about this all the time. 18:20 Healing does not happen overnight. 18:22 It didn't happen overnight. It doesn't change overnight. 18:25 But we can begin to shift the system immediately. 18:27 It is intelligent. 18:29 A little goes a long way, but it's like, I think this is inviting us back 18:34 into being kinder and gentler with ourselves and actually getting really 18:38 curious about what the body needs more of and what it means less of. 18:43 And when those ingredients come together, not only the healing outcomes, 18:48 but then the whole other trajectory of where we go from a longevity, 18:52 a capacity of resilience, 18:54 you know, an energy, a vitality and a liveness standpoint. 18:57 It's a whole new conversation. 19:00 Yeah, I love that. 19:01 And, you know, going back to the mitochondrial membrane. 19:04 And that was such a beautiful way to explain it 19:06 because I think at this point anybody who's listening it makes sense. 19:10 You know, you have a broken membrane. 19:12 You're bringing something in that's asking more of the system now the you know, 19:16 it does. 19:17 SS 31 does do some repair work on the cardio lipid correct aspect. 19:22 But if your phospholipids are not there, if that's the thing, 19:25 if the building materials for that membrane are not there 19:28 and you've been on a sad diet and you're eating a lot of denatured, 19:33 unhealthy fats and you're missing the fossil, you're missing the very, 19:39 the very pieces that are going to make that membrane sing.
Misconceptions, Dosing, and Terrain 19:43 Sometimes you're on a statin or you're on a statin. 19:46 Exactly. 19:47 And so sometimes you do that foundational repair work and you find that, oh, maybe 19:51 I don't need to spend thousands of dollars on that time. 19:54 Like there's a thought. Correct. 19:56 Sometimes doesn't mean. 19:57 But, you know, definitely. 19:59 Yeah. 19:59 If you do that foundational work first, never mind all the lifestyle stuff 20:03 that people are trying to skip over, right? 20:07 Yeah. 20:08 And I think that's one of the 20:09 and this here's a really interesting rub, gang, is that, you know, again 20:13 when look, sometimes when we have just been really in it like, 20:16 and we just are so desperate for a shift like the idea of just give me anything, 20:20 I'll buy it all, 20:21 I'll stick it all, I'll take it all, and I want the highest does 20:23 because I want to be on the other side of it. 20:24 Yeah, yeah. 20:25 I'm not I'm not taking that away from anybody. 20:28 I think we've probably all had a moment like that in some way, shape 20:31 or form in our lives that we're like, come on, can I just like, 20:35 I don't want to have to keep dealing with this thing anymore. 20:38 And so it's great that there is 20:40 something that if we really need a powerful kickstart, we can do it. 20:44 And yet I always tell my clients and my clinicians learning. 20:48 I'm like, for what reason? 20:50 What is it that we're really doing any of this for, 20:52 you know, what is it that we want? 20:54 Because because here's the rub. 20:56 We see like and we'll just use a GLP as an example. 20:59 One of the biggest issues that have happened with GLP is improper dosing. 21:02 And why. 21:03 Well, the higher we dose and even now you're seeing the new as well. 21:06 Hey, we're finding that 21:08 you could have even more weight loss if you even increase the dose more. 21:11 Well, people are flatlining. 21:13 There's a whole lot, you know, there's receptor overload like saturation. 21:16 There's a lot to that we don't need to get into on this conversation. 21:19 But my point is, is that think about it. 21:21 The more of the product that you use, the more you buy, 21:27 the more money that's made. 21:28 And so a lot of accounts, even on social media, have gotten 21:32 shut down talking about low dose, very low dose or the term micro dose. 21:36 Unbelievably so. 21:38 Right. 21:38 Because if we all of a sudden go, well, less is more. 21:42 And if we talk about, wait a minute, I can actually take lifestyle principles 21:45 because what is it that I really want more of? 21:47 If I really want to be better today for longer, tomorrow's I want to, 21:51 I want I've been chronically sick. I need some solutions. 21:53 Which peptides are phenomenal for chronic illness? 21:57 Like some of the most powerful things to add into the tool belt, you know, like. 22:01 And then what? 22:02 Well, then we get back to, I call it from sick care to health care. 22:05 We get back to stable. But that's not where the story ends. 22:07 That's where it just starts. 22:08 Because that's when we really go into, 22:09 well, care that longevity, that optimization. 22:11 And and you said it. 22:13 So I would encourage the consumer especially you know 22:17 always look at the money trail. 22:19 So these molecules work less can be a whole lot more. 22:23 And when we stack it with these other lifestyle principles and we really work 22:27 with, you know, we connecting community, we can extend health. 22:30 We don't need as much. 22:31 We don't have to buy as much. 22:33 And to your point, like we don't need to spend thousands. 22:36 We will have some substrate, some supplements, like some molecules there. 22:40 What's on the end of our fork that's going to nourish us in other ways? 22:43 Good sleep, good light, all those good things and we'll find 22:47 what's really coming down the pike, you know, is with telehealth 22:51 and the access points, we're going to see more and more of a democratization 22:55 and access to these molecules, and you're going to see them almost become 22:59 a commodity. 23:00 Prices are going to get driven down in a in a lot of categories, but 23:05 they're going to keep trying to 23:06 they're going to keep creating a problem to try to sell a solution. 23:09 Like there's a new, 23:10 you know, one coming to market that's going to help to preserve. 23:13 So take take to lose the weight and you're going to lose your muscle mass. 23:17 But I can't remember the name of the new drug that's coming out by Eli Lilly. 23:21 That's going to preserve muscle mass. Right. 23:22 So they're like, take this one to lose weight. 23:24 Take this one to preserve muscle mass. 23:25 You don't have to do a darn thing, but just keep buying the thing. And 23:30 I can tell you one thing. 23:31 You're not going to look so hot and you're so soon. 23:33 No, just putting it out there. 23:35 You're not. 23:37 Nor are you going to be necessarily. 23:39 I mean, you'll be at best, you'll be. 23:42 You'll be addicted to it metabolically. 23:44 At worst, it'll stop working. 23:46 Or you sacrifice your long term health for a short term fitting into your size. 23:51 Two genes like, yeah, it's you know, I think that I think one of the reasons 23:56 and you probably said 23:57 this people are so excited is because and particularly with the Globe's. 24:01 Yeah. Is it does present 24:04 and certainly the advertising would imply as a silver bullet. 24:09 Yeah. Right. 24:09 You can have your cake. 24:11 You might only be able to eat your cake. 24:13 Yeah. That might be the only thing you eat today. 24:15 But you're still going to look thin. 24:18 And the the point people are missing is at what cost. 24:22 Right. 24:23 Where you could be healthy, 24:26 maybe not quite as thin, but carry muscle and be more youthful. 24:31 Yeah, with less. 24:33 And I'm sure, I'm sure 24:36 that your audience is well versed on this. 24:40 Yet it's not lost, especially when you just made the comment you made. 24:44 Gang muscle is the currency of longevity. 24:48 Muscle is what keeps us metabolically healthy. 24:52 Muscle is what regulates glucose and insulin production. 24:56 And, you know, a big part of it on the back end that we're seeing, 25:00 of course, we know, like, 25:01 yes, on the front end, it's great that we are seeing people lose weight. 25:04 And to your point, at what cost? 25:06 So when we have the muscle wasting, right. 25:09 Because again, this is this is the part. 25:12 And here's the thing. 25:13 Like I literally just this past weekend I had I always have like in the airport 25:16 I'm walking through and they see me with my peptide university 25:19 on and literally at the delta counter, she goes, oh my gosh. 25:22 Like how do I how do I get help? 25:23 She's like my my primary care put me on and they've got me on 25:29 like I, I'm on this really high dose, you know, I don't know what to do. 25:34 And I don't think it's like I don't think they're giving me the right information. 25:39 Like. 25:39 And they didn't know, like they're like, something doesn't seem right. 25:42 I'm on this really high dose. I don't feel great. 25:44 I'm not really seeing the changes quite the way I'm losing weight. But. 25:48 And they don't know. 25:48 They know that they need to ask other questions. 25:51 They don't quite know what they need. They understand. 25:53 Like in the back part of this conversation is lifestyle and protein a muscle mass. 25:57 What does that even mean? 25:59 What is it even mean? 26:00 And so, you know, in the most simplified term, gangs like literally 26:04 our muscles, they they burn they burn the fuel. 26:07 The fuel is glucose. 26:09 When we have too much glucose, whether it's from food, whether it's from stress. 26:13 And that's the part of the conversation, I think that the average American 26:16 average person, we we get sold this idea of calories in, calories out, 26:20 and you're just too sedentary. That's not it. 26:22 That's only a small part of the conversation. 26:24 The real disrupter is and when I say stress, it's 26:28 physical, mental, emotional, chemical, environmental. 26:32 It's a load to the system that the body doesn't 26:35 have the capacity to handle because all stress is actually neutral 26:40 and good, is designed to put a load, put a demand. 26:44 The body is supposed to respond, learn, 26:47 come back, recover, integrate the learning. 26:50 And that's how the human system actually gets stronger. 26:52 More resilient is how we evolve as a human species. 26:55 But you know, we are not we are now overloaded constantly. 27:00 We're always doing this like 27:01 just the amount of energy coming into our brains every day, like the light, 27:05 the the, you know, the thought, to think, the stress, the hormones, 27:08 so that all of a sudden we start to lose that muscle. 27:13 We now are even more dysregulated with that glucose, 27:17 because that means we're fighting flight. 27:18 And so we're dumping glucose, glucose, glucose, 27:20 glucose from all the stress to like, you know, 27:22 I'm fighting and fighting, but we're sitting, we're doing 27:24 and we're just storing all that fat and we're pro-inflammatory. 27:28 Then that accelerates the rate 27:29 and pace of breakdown and dysfunction and disease and accelerates aging. 27:32 So it's just one big negative feedback loop. 27:35 All of a sudden the GLP comes in and says, 27:38 what I think are so great about it, and I'm sorry, we're going way off topic, 27:42 but this is one of the things that I think 27:43 it's celebrated, and I don't know if it gets really highlighted to the average end 27:47 user enough. 27:48 One of the reasons that we are seeing so many profound 27:52 metabolic shifts, it's not even just about the appetite. 27:56 It's actually what it's doing to the liver. 27:59 And how liver is, is we're not dumping as much. 28:02 So when that whole stress load comes 28:06 and we dump glucose, you know, I've heard this. 28:10 I'm not going to claim this as mine. 28:12 I will I will share it with Doctor Patrick Porter to hear him 28:15 say he goes, listen, it's on average of a candy bar. 28:17 And I like I like real simple metaphors. 28:19 We're dumping about 24g of glucose, right? 28:22 Like so almost a candy bar. 28:24 Every single time there's a stress event, the system's overloaded 28:27 because it's like, I got to have enough fuel in the tank 28:29 to go run to get away from the Sabertooth Tiger. 28:32 So when we're having all these micro events and the systems overloaded 28:35 day over day, and we are just slow dripping and sometimes dumping 28:39 glucose, taking the GLP 28:42 is slowing down the amount that's being dumped. 28:46 So now we're not putting as much in even though we're still in these stressors. 28:50 Okay. And that's one of the greatest places. 28:52 Yes it's digestion. Yes. 28:54 It's slowing that down. Yes. 28:55 It's working with the dopaminergic. 28:57 You know, the reward centers and it's quieting food noise. 29:00 All of that is great. 29:01 But the beautiful opportunity it is. Yes. 29:05 Let's go. Move. 29:06 Because even movement helps our mental emotional decreasing stress. 29:10 Right. 29:11 But use these if we understand that this is a tool in the toolbox 29:16 and that it opens when I talk about them 29:18 not being the solution but the gateway, right?
GLPs, Muscle Loss, and Metabolic Health 29:20 They open a door into really being able to access 29:24 the tools that help us become our best version of us. 29:27 Meaning, 29:29 if your body is now responding to stress easier, it's not as hard on your system. 29:34 What if you now now what if you now 29:37 have access to tools 29:40 that are mentally, emotionally helping you to better 29:44 regulate that stress and or you're learning how to reduce or remove 29:49 some of those physical or environmental toxic burden loads, things like that. 29:53 So all of a sudden you're releasing other things 29:56 that would otherwise way your system down, stress you out, keep it going, keep 29:59 you breaking down, breaking down the muscle aging you faster. 30:02 Use the tool and dive into the real transformation. 30:05 I mean, I think that's what they open the gateway to. 30:08 Yeah. And exactly. 30:09 And the word transformation in case anybody missed it, it's not just physical. 30:13 It's a transformation of your mental. 30:16 It's a transformation 30:18 of how you treat your body and yourself, how you take care of yourself. 30:22 Because, you know, we talk about exercise, sleep, 30:25 stress management, all these things like their jobs. 30:28 But if you really think about it, what is it really? 30:32 It's loving you. 30:33 It's taking care of this vessel you were gifted. 30:36 So if we can just reframe that 30:39 and, and say, wow, you know, like this compound 30:43 gives me the space and the quiet 30:46 to actually get reacquainted with myself and relearn how to take care of me. 30:51 All of a sudden, it's no longer this horrible big mountain to climb. 30:55 Yeah, right. 30:57 Yeah. 30:57 And I've heard so many people that have been shamed, like 31:00 they get a lot of shame, especially around go, which is so unfortunate. 31:04 It like, hurts my heart. 31:05 So I think for anybody and I, you know, I really want to first really celebrate 31:10 anybody that's listening to this, anybody 31:12 that's here on your summit and taking this in because that means 31:16 and let me also give you this caveat, it's not always about more and more and more. 31:21 And you need more information and more information and more information. 31:23 If you can take one small thing away and just start there. 31:28 And honestly, like if the only thing you can do is start with a GLP, amazing. 31:33 But you don't have to go to big doses. 31:35 It's understanding and this is a whole other conversation. 31:38 It's not about the dose, it's about the level of what it does in the body, 31:42 because it does last and it takes upwards of five weeks. 31:46 The way the pharmacology of these molecules actually break down, 31:50 like it takes time for the stuff to get out of the body. 31:53 And we don't need as much as we once thought that we did 31:56 to really get beautiful results. 31:57 But if you were to just start there, and then from there, you start to realize 32:00 like, oh, I, my, my brain isn't as noisy. 32:04 I'm not thinking about I'm not thinking about all the things. 32:07 I'm not as angst up. 32:08 I'm, I'm not really anxious about when to eat, what to eat. 32:11 Will I eat, won't I eat, or I'm not as addicted to my phone 32:14 or as I'm not because it starts to again, quiet a lot of those 32:18 kind of addictive tendencies. 32:21 Now we can go so high we can ultimately blunt and go the other way over time. 32:25 It is the other side to this. 32:26 But when we look at it as an on ramp and we understand 32:29 lower doses, we understand like it gives me ease. 32:33 I'm not fighting myself as much anymore. 32:35 Yeah. 32:36 And then again, there's the doorway that opens into a little bit like, 32:39 what is it like when I'm not fighting myself as much? 32:42 What is it like when I want to just go take a few minutes, 32:46 even if it's just a few minutes and relax on the porch and do nothing 32:49 but the phone down, just let the sun hit my skin, right? 32:53 It doesn't have to be some big grandiose thing. 32:55 And I think we always over. 32:57 We always think it's more and more and more, but oftentimes first 33:00 and foremost in healing and then in really like living an abundant life. 33:06 It's actually about less. Yeah. 33:09 And it's just like it's streamlining and just feeling the fields of the space 33:14 in between because we just put more and more and more. 33:17 It's like what makes a great piece of music? 33:19 It's the space between the notes and we always put so much in. 33:23 We don't create space just to feel and appreciate 33:26 and kind of come back to center. 33:27 So I love these molecules, do all sorts of wonderful things for us. 33:30 Beautiful and so full circle. 33:33 To be clear, we are fans, both of us just used appropriately. 33:37 So yes, us to our next question. 33:40 Given all the noise out there and all the voices fighting for attention. 33:45 How do people know who to trust right now? 33:49 Is it the person with the million followers? 33:51 Is it the person with 10,000? No. 33:53 Why do people know who to trust? 33:55 Listen. Where? I think a lot of people are going. 33:58 So I agree. 33:59 And a lot of people are following the influencers. 34:02 Now, the first thing I'm going to say to you is are they selling peptides? 34:07 Yeah. 34:08 If everything they're doing is to educate you, for you to buy a peptide from them, 34:12 chances are they're they're not 34:17 they're not the one for you to fully go deep with because and I'm not like, 34:21 listen, as healthcare practitioners we have to always reveal 34:25 any conflict of interest. Right. 34:27 So meaning like and at Peptide University we're the education arm. 34:31 We don't sell peptides through us. 34:33 However people come to us all the time. 34:34 Now there's a whole other division under Human Longevity Global 34:38 that makes the vets vendors just like Natalie like you do. 34:41 Like we get asked. 34:43 So but I'm never going to just give one. 34:45 I'm never going to just endorse one. 34:46 Because now all of a sudden I have a conflict of interest. 34:49 But if my team goes out and vets and looks and says, what makes one company 34:54 better than another or as good, or who can you trust and why? 34:58 You know, it's not just because we're getting a commission from them at all. 35:02 It's we literally have walked into the pharmacy. 35:04 We've been into their sterile room. 35:06 We've looked at their reports from the state board, from the national board. 35:09 We've done background checks like there's so much criminal activity in the space. 35:14 There's a huge influencer right now, no names mentioned, 35:17 that has criminal activity and has one of the largest followings. 35:22 It's like, okay and we're okay. 35:25 And I know we're all hungry and eager. 35:27 So of course I'm going to tell you to come to my peptide university 35:30 to come get educated. 35:31 But we also we are clinician first, but we also for the consumer 35:35 we help to connect to with trained clinicians. 35:37 But I think that the most simplified way is whomever 35:41 you are looking to work with, find out where they've gotten trained. 35:45 So there's only a few of us out there. 35:47 There's only a few entities that actually have, you know, 35:51 verified accredited certification programs. 35:55 So for example, we have two national, one international 35:59 accreditations were endorsed by the American Peptide Association. 36:02 We are CME, we are Siu. 36:05 We're in. 36:05 So that means we have, you know, everything from the fitness industry. 36:09 We have accreditation with up to the medical industry 36:12 and the National Board of American Medical Association. 36:15 We have had malpractice groups review our curriculum so that we know that 36:20 it doesn't matter 36:21 if you're a prescriber or non prescriber, you're coming through our programs. 36:24 The rigor is there, the evidence base, the clinical framework. 36:27 It's not just about the molecules. 36:28 So ask them if they've been certified. 36:31 Ask them where they've got trained. 36:32 Look into it. 36:33 And if they're just trying to sell you a peptide, chances 36:37 are there the wrong person. 36:39 So we train our clinicians all the time. 36:41 You're not there to sell a peptide ever. 36:44 And as licensed clinicians, we're not supposed to be marking up medications 36:47 like you're there to sell outcomes. 36:49 You are there to and you're not even there to sell. 36:51 You're there to support and facilitate. 36:53 Yes, consumers are going to pay. 36:55 This is a cash pay space. And there's nothing wrong with that. 36:58 You actually want safe results. 36:59 You want somebody that's educated, informed, will guide 37:03 you, will support you. 37:04 It's more than just a research China $80 and you don't know 37:08 if you've just put massive endotoxins in. 37:10 You've flared up your mast cells and now all of a sudden 37:12 you can't understand why your autoimmune is so bad and the weight won't come out. 37:15 You know what I mean? It's like, I never mind $80 from China. 37:18 We're talking like ten bucks sometimes. 37:19 Like, well, yeah that too right then. Excited 37:23 of the backlash. 37:25 So education matters. 37:26 And I think just ask those informed questions. 37:29 You know we are going to it's not front facing public yet. 37:33 It may be at the time that this 37:34 interview airs we will also be showing kind of our grading system. 37:38 And so some of the things that we are going through with vendors of how we and 37:42 we haven't 37:42 got to rate every company out there, but we are putting a very curated list, 37:46 like what is making who's passing the mark, so to speak. 37:49 So do your due diligence. 37:50 Don't just trust that 37:52 if it looks too good to be true, it's probably too good to be true. 37:56 And there are downstream effects of what that could mean 37:58 for you, for your health and and your overall results. 38:01 Yeah. 38:04 Do you think 38:04 people should be navigating peptides on their own? 38:07 I mean, gosh, there's so much of that around. 38:10 I do not I don't I mean it's like and it's 38:13 simply it's not that as individuals were not intelligent. 38:16 I mean, when I'm telling you that even my doctors end up in the hospital 38:20 and I'm not trying to scare anybody because these are really and again, the 38:25 I think the error that we all make is like, well, they're just amino acids. 38:30 They naturally occur in the body. 38:31 That must mean and, 38:32 and we hear things like a BPC that has one of the greatest safety profiles, 38:36 like we cannot find the point of where that toxicity level hits. 38:40 Right. 38:40 Like so there is a lot of safety, but there's also there's still guardrails. 38:44 And just because something is safe or it is naturally found 38:48 in the human system or in nature, like with bio regulators as an example, 38:53 it doesn't mean that that's the right molecule, the right fit for the 38:57 right out for the outcome that you want in your system under your circumstances. 39:02 At this time, it might be it might be exactly right. 39:05 But, you know, we just think, well, then we keep stacking things on 39:09 and then we can't figure out if have people send me pictures. 39:11 Why is my lip blue? Why did this happen? 39:13 Like I'm just like, well, I can't just give you a simple answer. 39:16 I have to ask you all these questions. 39:17 I have to look back because it's never just one thing.
How to Trust Clinicians and Vendors 39:20 And that's what we think is the consumer. 39:22 I'm going to do the thing I'm going to get. 39:23 The thing is all going to be fine. 39:24 Then when things go sideways, we're like, what? 39:26 The actual flip flop work with a trained clinician in the space. 39:33 So if you if you really, truly care about the result, 39:35 like if you're just playing and dabbling, all right, 39:38 you know, maybe you're going to do it on your own. 39:39 I'm not going to fault you for it. 39:40 And of one man go like be your own sovereign advocate yet 39:45 find trained, trusted communities. 39:48 You know, that's why we that's 39:50 what we built our platform at my peptide university. 39:53 Yeah. Yeah. 39:54 And it's a great community. 39:56 So last question, my dear friend. 39:59 Well, second to last. I'm sure I'll have another one after this. 40:01 Why do you think so many clinicians are suddenly trying to learn the space? 40:05 Like definitely lots of people racing to jump on this bandwagon. 40:09 Do you think it's because they're recognizing 40:11 how powerful they are, or are there other reasons like what do you 40:15 what do you think? 40:16 It's that. 40:17 And so the the biggest reason is the consumer demand. 40:21 So consumers are coming in asking they're on a GLP from somewhere 40:25 whether they've sourced it on their own, whether they went, 40:28 you know, so so they're coming in and they're asking questions. 40:30 And this is exactly kind of where we started. 40:32 Why there's so many voices out there now saying this is hype, this isn't real. 40:36 This is an evidence base. 40:37 But there's the other, 40:38 there's many, many more that are leaning in going, no, it's real. 40:41 I'm watching it. 40:42 It's walking in and my clients and patients are asking me for it. 40:45 And there's the very real awareness that's like, wait, I'm getting left behind. 40:49 This isn't just a trend. 40:50 This is not. 40:52 I'm telling you. 40:52 These are not vitamins. 40:53 It's not just a company that's going to all of a 40:55 sudden have a hype and be gone in a couple of years. 40:57 It's not a passing trend. 40:59 Now, access direct to consumer access in the way that we've had it. 41:03 That is going to change. 41:04 So the people that really and end when you have groups like ours 41:08 and you see all of a sudden the administration talking about it 41:11 like the legislation changes, we're out there being a big advocate. 41:14 Like, listen, clinicians, 41:16 you got to get trained because if you haven't, you can't dabble 41:19 in either more the clinic, the consumer, I mean to you. 41:22 And we're going to see more and more gatekeeping 41:25 to the direct to consumer research access. 41:27 And so more and more it is going to come by way of 41:30 you've got to work with in conjunction with a clinician. 41:33 And there are ways for both prescribers and non prescribers 41:37 to access these things. 41:38 So it's not all just on the script pad. 41:40 It depends on what molecule you want and how you want to use it. 41:43 So when I say there's kind of different access points or shades of gray 41:47 and what I said earlier, I don't mean the gray market. 41:49 I mean it's not to say this is it. 41:50 You can only write a script, and that's all. 41:52 But for our licensed physicians, 41:55 they write the script, they work with the compounding pharmacies. 41:59 They've got to protect their license and, 42:01 you know, malpractice risks and all of that. 42:03 So it's they need training because they know they're getting asked 42:07 and they're like, Holy moly, I can't put anybody at risk for the non 42:12 prescriber who is working with these outside 42:15 of a compounding pharmacy or who's moving into an integrative model. 42:18 Because really and truly, if we want GLP, that's the main way 42:23 everything is going to go more and more and more through compounding. 42:26 And there's going to be some supplement lanes 42:28 and they're still going to be oral delivery routes, like 42:30 we're going to see different innovation come to market. 42:32 But I guess the short answer is I'm a little long winded. 42:36 The doctors know they're not going away. 42:38 The landscape is changing. 42:40 They know that if they don't get trained today, they get left behind tomorrow. 42:43 And and they don't want to they don't want that. 42:45 They want to. 42:46 They want to leave. They want to stay future focus. 42:48 And they truly care about the clients and patients they serve. 42:50 So they want to be able to show up, 42:52 you know, with just with the best resources possible. 42:55 So I commend every clinician saying yes, leaning in and getting educated I agree. 43:01 Yeah. All right. 43:02 So there's been a lot of noise lately about this. 43:05 What's happening in July. 43:07 Yeah. 43:07 So we have people screaming guess what. 43:10 It's all going to be legal in July. 43:12 And then you've got other people like me saying guess what. 43:16 No they're not. 43:17 Well not not which is a good thing. 43:21 But what is going on? 43:23 Like what do you think really is going on and how long is it actually going to take 43:28 in your opinion? 43:29 Like are they basically just gathering 43:31 information from clinicians who've been using these in practice 43:35 so that they can call, you know, I don't want to use the word cobble 43:39 because it doesn't sound good enough, but so they can really create 43:42 a true image of what is happening with these compounds. 43:46 Or, you know, what I've heard is their B each one is being measured against 43:50 a very specific clinical presentation, which on the one hand is great. 43:55 And on the other hand, especially in the case of a BPC 157 43:58 is a bit heartbreaking because there are so many other clinical 44:02 applications that it is helpful for. 44:06 Yeah. 44:06 What's going on, doctor Melissa? 44:09 Tell us as our final kind of yes. 44:11 And this could have been the whole interview just now. 44:15 So let me I'll work in reverse. 44:18 Let me say this, that here's the great news. 44:20 Once they do get 44:22 on the one hand, like once we have one 44:25 use case, we can begin to have off label use. 44:29 Yeah, I was hoping to say that. Yeah. 44:30 So from a clinically and this is why you want to work with clinicians. 44:33 Meaning they have to understand. 44:35 And for the clinician if you haven't been trained on this 44:38 you do have to understand what does an informed consent look like. 44:41 What is the process of an off use case. 44:43 How do you have to notate this in your EHR? 44:45 Like, you know, you've got to have a paper trail. 44:48 You've got to be making sound clinical reasoning and decisions. 44:51 So you do need to know the science. 44:53 You do need to know the mechanisms of action. 44:54 You do need to understand why you would choose this in that way. 44:58 For what reason? 44:59 Okay. 45:00 So I think it and here's what I'll tell you. 45:03 Like I've got some of it's my opinion, some of its I'm lucky enough 45:06 to get to be in the back room to be, you know, here 45:10 I was with somebody who's like, I'm sitting down with RFK next week. 45:13 They want like it's interesting how they, they meaning kind of the legislation 45:18 or the administration rather is crowdsourcing from some of the top 45:21 movers and shakers who have had access to have got companies in. 45:25 It's also interesting to see some of the compounding pharmacies 45:29 that are, you know, some of the big ones have a lot of a lot of financial interest. 45:33 They've invested a lot. 45:35 And so they've got the best of the best attorneys. 45:37 They've got the best of the best lobbyists like to see how things are, 45:41 how everybody's playing together. 45:43 Here's the real shakedown. 45:45 The reality is, you know, for the longest time 45:48 and I don't know if here it is exposé that, you know, pharma didn't really care 45:53 much about peptides because they couldn't necessarily patent because of, you know, 45:57 there are naturally occurring, however, they know how to patent everything else. 46:01 Delivery system, fermentation systems names the molecule structure 46:05 like they're brilliant once they cracked the code on like, wait a minute, 46:10 okay. 46:11 And to see what the glasses have done, here's this is my opinion. 46:16 I'm not going to say that this is fact. 46:17 If you just pull back and you look at it and if you really understand, 46:22 you understand politics, you understand the mob, you understand 46:25 like you know who's got their hands and what pie you look and you go,
July Regulatory Changes and the Future 46:30 all right, this is a real clear story of now that they've cracked the code, 46:34 and you look at some of the molecules that are being reassessed, right. 46:38 You look at BPC to have control over BPC and what that could do. 46:43 Right. 46:43 Like and as an example and once if, when and as they decide to lock that down. 46:49 And I think they're really vetting and testing. 46:52 Well which ones would make the most sense for us to do next. 46:55 They've already got other ones coming out 46:56 like they've already got a whole pipeline, they've got longevity molecules 46:59 that are coming. 47:00 You know, pharma is in the peptide space now, gang they're in. 47:03 And they're here to say they're not going away. 47:05 They understand the monetization. 47:07 And they also and hey, the one good thing I'm going to say is 47:10 they're actually using molecules that can make a difference. 47:12 The only downside is they're still pushing high doses 47:15 that don't actually help the end user charging a ton of money. 47:19 They're making loads of money. 47:21 It boatloads of money, you know. 47:23 So funny side note just yesterday I was on good. 47:27 I was doing I was so I was a bit with a big pharmacy. 47:29 And we're looking at pricing and looking at all the cost of the API, 47:32 everything from nuts to bowl to all the stuff. 47:34 And so if you think about it, a year ago, even probably even six months 47:38 ago, would have cost the average person like it. 47:42 At first it was over 1300, right? 47:44 At one point it was 1600, then it was 1300, then it came under a thousand. 47:49 Then it was like 750, then it was 500. 47:51 So $149, like $129. 47:55 I'm like, okay, and let's just think about that. 47:59 How do I. Lily? 48:01 Yeah. Or is it. Eli. It's Eli. Lilly. 48:03 Yeah. 48:04 Holy jumping. Yes. 48:05 They're good recs, right? Wow. 48:07 And so now think about that. 48:09 I'm like and and like gang I mean, you look at that. 48:12 The swing of money 48:13 how that at the height and there's many guys because nobody 48:17 in the form of business is losing money. 48:18 Let's be clear now I will also say this. 48:21 Listen, the whole way it works in the back end is they have to decide. 48:24 Is it like there's a lot of money that goes into bringing a drug to R&D 48:28 is a real thing. Sure. 48:29 So all of it is like, Will I will there be an eye? 48:32 Right. 48:33 So all of this is there kind of like, well, 48:35 okay, where are we going to get a piece. 48:37 And so we don't want you to touch hands off our GL and a hands off 48:42 we're about to bring out because we know we've hit the big lever movers, 48:45 but we're going to give you guys access to some of the other things 48:49 so that we can calm you down. 48:50 And so there's a little bit of let's 48:52 figure out how we can play nice in the sandbox. 48:55 And you know, because again, like at the end of the day, 48:58 they want doctors to write scripts to sell this stuff, 49:00 to move the stuff for them because the doctor doesn't make anything. 49:03 They're just moving it for them, so to speak. 49:06 What a terrible way to think about it. But that's kind of what it is. 49:08 It's like crazy. 49:10 So from that standpoint. 49:11 So anyway, I think there's the way I like it is that at least it's not perfect. 49:17 And there is still there's money behind all of it. 49:20 But at the same time there is benefit. 49:22 And when you have amazing 49:23 trained clinicians, heart centered clinicians, boots on the ground 49:26 there in the integrated space, they care about the humans 49:30 they are serving, and they're not going to just write it 49:32 one and done it like they're like, wait, there's intelligence here. 49:35 There's nuance here. We have access to other things. 49:37 We can drive better outcomes and results. 49:40 It gives the clinician hope and and real resources to not just manage problems, but 49:45 it gives them real tools in the toolbox besides surgery to remove something, 49:50 to actually go in and work with the intelligence of the body, 49:53 bring healing back into the system and actually enhance results 49:57 for the patients they serve. 49:58 And it gives that that end user, that consumer, that patient, it gives them 50:02 not just hope, but it gives them a real result and a real outcome. 50:07 So I do believe the process has just beginning in July. 50:11 It doesn't mean they're back. 50:12 It means it's given us a lot to talk about, to have interesting conversations. 50:16 Things are going to trend, but that just means 50:18 what are we distracting here, what's really going on in the background. 50:21 So we're just going to see Lilly, you know quarter over quarter 50:24 dropping more things. 50:25 They're going to ride the GLP train as long as they can. 50:28 It's going to get so commoditized that we're going to see it. 50:32 You know I was in a session I had the fortunate 50:35 opportunity to sit down with Mark Cuban back at South by Southwest. 50:38 We were in the green room together having a conversation. 50:41 And he literally said his quote was, we were going to see 50:44 GLP be over-the-counter in less than 18 months. 50:48 Yeah, I wouldn't be surprised. 50:49 You know, less good candidates for that. 50:52 You know, it's it's. Yeah. 50:54 And so if we look at that arc like we look at that arc, it's not just about a P. 50:58 It's like we're going to see more intelligent molecules coming. 51:01 We're going to see more access. 51:03 You know, we are going to see it. 51:04 And there's always going to be money moving behind it. 51:07 And without trying to demonize anyone, I think regardless of 51:12 if it's pharma, if it's a compounding pharmacist, if it's an Ruo group, 51:16 if it's a gym, bro, we wouldn't be here if it weren't for the gym bros. 51:20 Yeah, having the 51:22 conversation, pushing it forward. 51:24 I'm I'm grateful to pharma for all the R&D, for all the innovation 51:28 because I personally freaking love what GLP at very low 51:33 doses are able to do what we're seeing early in the literature, 51:37 the the role they're going to play in longevity, 51:40 in healing and, you know, inflammatory mitigation, like true quality of life, 51:46 like they really can help to be a powerful player in optimizing the human system. 51:51 So regardless of where we enter from, I'm not here to bash anybody. 51:55 I think we get to crowdsource. 51:57 We get to learn. 51:58 I just want everybody to be intelligent. 52:01 Don't just take something at face value. 52:03 Be curious, understand 52:04 what are the motives behind it, you know, and what feels right and aligned. 52:08 Say yes to that. 52:09 If it's working with a clinician, if it's coming on to a platform like this, 52:13 if it's learning about a telehealth platform 52:15 that you feel really aligned with, whatever, whatever your entry point is. 52:18 But that just means to me that you are 52:22 taking ownership of your own health. 52:26 You're not, you know, 52:26 you're leaning in, you're learning, and you're saying yes to you. 52:30 And at the end of the day, I'm not here. 52:32 How to tell you to do that? 52:33 I'm just celebrating that you're doing it, you know, because it's about 52:37 how do we support ourselves better today for a longer, more vibrant tomorrows 52:42 when we do that, when we start with self first in the moment, right now, to me, 52:46 I see the transformation that can happen in the world. 52:49 I don't believe in a world that's gone to hell in a handbasket. 52:52 I see so much beauty. 52:53 I see so much evolution. 52:55 I see so much possibility. 52:58 And not just hoping, but like real things that will happen. 53:02 But it begins within ourselves. 53:04 And so I think this is, again, a beautiful gateway 53:07 into a really amazing future for all of us. 53:11 Beautiful doctor Melissa, thank you so much for your time today. 53:15 Thank you. Darlene, where can people find you? 53:18 Where can they find out more about my peptide University? 53:21 And by the way, it's my peptide university. 53:24 Not just peptide university. 53:26 There's there's a there's a a fake out there. 53:29 Yeah. So we're not we're. Yeah exactly. 53:31 You're not going to get the things that you would get with us. 53:34 So mypeptideuniversity.com for all things peptides. 53:39 And we are moving a lot of our longevity certifications. 53:42 And they're now that typically live over at Human Longevity Institute. 53:45 So it's kind of everything from the small molecules. 53:47 And this is both the clinicians. 53:49 We have a coaching program that's coming out for those of you 53:52 that are in more of that coach realm, 53:54 as well as longevity medicine, regenerative medicine. 53:57 So we have one of the most incredible 54:00 faculties on the planet, and I'm proud to say you're a contributor to that. 54:04 You know, you're so busy and so full, but when you're free, 54:06 you're able to drop in and share your brilliant. 54:09 And it makes all the difference in the world. 54:11 So I'm proud of who we are, who we attract, my peptide university 54:15 and just kind of in general I you know I 54:19 you can follow us there on socials human longevity global.com Doc Melissa 54:25 I mean you know it just checks out my Melissa right Melissa. 54:29 Yeah that'll do to all the things me love it Doc Melissa thank you so much. 54:34 Always such a joy to spend time with you. 54:36 And I can't wait I think I get to see you next week. 54:39 Really looking forward to that. 54:41 Live and in color. 54:43 Thank you so much. Thank you.
Comments